# 2026-09-02

Phase B ran once today: **08:38:46 CT** (the standard 8:35am scheduled run).
`execution.mode` is still `dry_run` in `risk_rules.json`, so the live-order
gate was closed regardless of outcome (and would have been closed anyway —
the dry-run cycle count is only 7 of the 10 required).

## Account state

No open equity positions. Account value $762.04, all of it cash. Because
nothing is held, the stop-loss, take-profit and conviction-trim checks had no
positions to run against this cycle, and there were no `exit_existing`
candidates from Phase A.

## Loss-limit check

Re-run fresh, as required every cycle: realized P&L is $0.00 today and $0.00
this week (0.0% / 0.0% of the $761.44 starting capital, against limits of 5%
daily and 10% weekly). **Entries not halted.**

## Candidates considered

`pending_proposals.jsonl` is unchanged since the 2026-09-01 16:39:39 CT
Phase A run (`proposal_date` 2026-09-01): six `direction: long` candidates —
MMED (high), VRT (high), MRVL (low), AMD (high), DELL (low), NVDA (high) —
plus four `direction: avoid` calls (FRVO, INTC, SUNB, SPCX, not processed
further) and no `exit_existing` candidates.

- **AMD, DELL, NVDA** already had a `risk_check`/`order` entry in
  `trade_log.jsonl` with matching `proposal_date` 2026-09-01, logged by
  yesterday's 03:56:29 CT cycle. Per Step 0's idempotency rule (keyed on
  `proposal_date`, not today's date), none were re-evaluated this cycle.
- **MMED** — rejected: only 1 of 2 required consecutive cycles available
  (`thesis_stability`, first appearance in `thesis_history.jsonl`).
- **VRT** — approved: thesis-stability stable (long across 2026-09-01 and
  2026-08-31; conviction drifted high→medium, sized off the lower, medium),
  buy gate clear (gap -1.44%, extension -5.81% vs. 20d MA). Sized at
  **$91.44**.
- **MRVL** — approved: thesis-stability stable (long across 2026-09-01 and
  2026-08-31, conviction stable at low), buy gate clear (gap -2.04%,
  extension -7.70% vs. 20d MA, wash-sale check clean — MRVL's realized losses
  in account 506946300 are all 55+ days old, well outside the 30-day
  lookback). The -2.04% gap was re-checked against the thesis's invalidation
  criteria — Marvell's Aug 27 Q2 print raised both FY2027 and FY2028
  guidance rather than cutting it, so not invalidated. Sized at **$45.72**
  (risk_flags: dilution_risk).

VRT and MRVL together fill 2 of `max_concurrent_positions` 4, leaving
$624.88 cash (88%/82% cash buffer after each, both above the 10% minimum).

## Orders

Two buy orders reviewed, both `dry_run` (no live orders placed —
`execution.mode` is `dry_run`):

| Symbol | Side | Est. $ | Est. qty | Ask used |
|---|---|---|---|---|
| VRT | buy | $91.44 | 0.356686 | $256.36 |
| MRVL | buy | $45.72 | 0.220667 | $207.19 |

`review_equity_order` returned no blocking alerts for either.

Dry-run cycle count now **7** distinct dates (2026-08-24, 08-26, 08-27,
08-28, 08-31, 09-01, 09-02) against the **10** required before the
live-order gate can open.

_(Convenience view only. `trade_log.jsonl` is the source of truth; if the two
disagree, trust `trade_log.jsonl`.)_
